# Session Summary — Session 015
## Status: SUCCESS
## Reason: 2 PASS + 4 CONDITIONAL_PASS hypotheses from percolation x T cell infiltration target. Global novelty confirmed (zero papers found bridging percolation theory and T cell immune exclusion). Zero citation hallucinations. Early-complete from cycle 1 (top-3 composites all >= 7.0).
## Contributor: Anonymous

---

## Target
**Percolation Threshold Theory x T Cell Infiltration in Solid Tumors**
- Field A: Statistical mechanics -- bond percolation theory
- Field C: Tumor immunology -- ECM-mediated immune exclusion
- Strategy: structural_isomorphism
- Disjointness: DISJOINT (0.90 confidence)
- Impact potential: 9/10

## Pipeline Statistics
| Phase | Count |
|-------|-------|
| Scout targets | 6 |
| Selected target | T1 (composite 7.25, PROCEED) |
| Computational readiness | HIGH (9/11 checks) |
| Hypotheses generated | 8 (7 techniques) |
| Survived critique | 6 (25% kill rate) |
| Evolved | 6 |
| Quality Gate | 2 PASS, 4 CONDITIONAL_PASS, 0 FAIL |
| Cycles run | 1 (early-complete: top-3 >= 7.0) |
| Citation hallucinations | 0 |
| Factual errors | 1 (3D DP exponents confused with 1D values in E3/E4) |

## Final Hypotheses

### PASS

#### 1. E1 -- LOX Crosslink Density as Percolation Control Parameter (PASS, 7.85/10)
**LOX-mediated collagen crosslink density maps to bond occupation probability p, producing a sharp immune exclusion phase transition at p_c ~ 0.21-0.24 (active percolation, Pe~3).**
- Wolf 2013 pore-area threshold (4 um^2) corrected from original 3 um; defines open/closed bond
- Intratumoral heterogeneity smearing quantified: sigma_p ~ 0.06, Delta_p ~ 0.12, apparent Hill n_app ~ 2-4
- Order parameter exponent beta = 0.41 distinguishes from Hill-equation pharmacology
- All 7 grounded claims verified; 0 hallucinations
- **Falsifiable prediction**: Sharp sigmoidal transition in T cell infiltration at critical collagen crosslink density; log-log slope beta = 0.41
- **Test**: 3D collagen gradient (2-20 mg/mL) + CD8+ T cell tracking + SHG network extraction
- **Application**: drug target + measurement | Immuno-oncology | near-term

#### 2. E2 -- BAPN Dose-Response as Percolation Phase Transition (PASS, 7.80/10)
**BAPN (LOX inhibitor) dose-response predicts sharp nonlinear phase transition in immune infiltration; p(dose) derived from Michaelis-Menten LOX kinetics.**
- Tang 1983 citation corrected (was incorrectly cited as 2017)
- p(dose) function modeled via LOX Michaelis-Menten kinetics (K_I ~ 50-200 uM cellular, d_c ~ 50-150 uM)
- Cooperative LOX concern resolved: LOX is monomeric enzyme (confirmed UniProt)
- In vivo dose broadening quantified (2-4x)
- All 4 grounded claims verified; 0 hallucinations
- **Falsifiable prediction**: T cell infiltration vs BAPN dose shows power-law onset with exponent beta = 0.41, not Hill curve; same exponent across tumor models
- **Test**: In vivo BAPN titration (8-10 doses) x 2 tumor models + pyridinoline crosslink assay
- **Application**: drug target | Clinical immuno-oncology | near-term

### CONDITIONAL_PASS

#### 3. E6 -- VACF Percolation Fingerprint (CONDITIONAL_PASS, 6.75/10)
**Velocity autocorrelation function (VACF) replaces MSD as percolation diagnostic. Percolation signature: negative dip C(tau_min) < -0.1 at tau ~ 0.5-1 min; run-and-pause gives C > 0.5 (5x separability gap).**
- Passive-bead control proposed to isolate ECM topology from active motility
- tau_min derived from fractal walk dimension d_w = 3.8
- 1 unverifiable citation (Weiss 1976); underlying claim correct

#### 4. E3 -- Universality Class Measurement (CONDITIONAL_PASS, 6.25/10)
**Measure critical exponents rather than assume isotropic percolation. Hypothesis inverted from "nu = 0.88" to "what is nu_eff(Pe)?" Microfluidic Pe-control chip proposed.**
- 3D directed percolation exponents incorrectly cited as 1D values (nu_perp = 1.10 should be 0.584 in 3D)
- ~20-30% of CRC MSI-high tumors estimated near p_c

#### 5. E5 -- MMP/LOX Dynamic Percolation Clock (CONDITIONAL_PASS, 6.25/10)
**MMP/LOX kinetic balance creates time-dependent p(t). Partial correlation vs Salmon 2012 fiber alignment proposed as discriminator.**
- LOX-crosslinked collagen t_1/2 = 12-120h quantified
- Scope limited to tumor-stroma interface (100-200 um)
- Orgel 2011 unverifiable; timescale mismatch concern

#### 6. E4 -- Gradient Anisotropy Score as Pe Classifier (CONDITIONAL_PASS, 6.05/10)
**GAS = |gradient(CXCL9)| / sigma from standard IHC replaces anisotropic correlation lengths as simpler observable.**
- Same 3D DP exponent error as E3
- Pe_eff formula addresses gradient-variation reversion
- Retrospective study design; 15-25% effect size

## Kill Patterns
- **H5** (Finite-size biopsy scaling): KILLED -- predicted 0.6% shift is 2-3 orders of magnitude smaller than intratumoral collagen heterogeneity. Physics correct but effect negligible.
- **H7** (Backbone = functional T cells): KILLED -- mechanism contradicts established T cell exhaustion biology (Wherry 2011, Nat Immunol). Exhaustion is antigen-driven, not caused by physical confinement.

## Key Session Insights
1. **Global novelty confirmed**: 25+ web searches found zero papers applying percolation theory to T cell infiltration in tumor ECM
2. **Structural isomorphism strategy**: Second primary session (after S011). 33% PASS rate, 100% PASS+COND rate -- matches S011 performance
3. **Active percolation mandatory**: Pe~3 for T cells requires active percolation framework throughout; passive p_c = 0.2488 is insufficient
4. **Prior art scoping works**: All hypotheses successfully differentiated from Ashworth 2015 (collagen scaffolds, tissue engineering)
5. **Citation quality**: Zero hallucinations across 17 audited claims. 1 factual error type (DP exponents wrong dimension)

## Remaining Scout Targets (for future sessions)
| Target | Score | Verdict | Disjointness |
|--------|-------|---------|-------------|
| T3: Classical Nucleation Theory x Ferroptosis LIP | 7.0 | MODIFY | DISJOINT (0.97) |
| T2: Acoustic Filter-Bank x Plant Bioacoustics | 7.0 | MODIFY | DISJOINT (0.88) |
| T4: Viscoelastic Creep x Biofilm Tolerance | 7.5 | PROCEED | PARTIALLY_EXPLORED |
| T5: Griffith Fracture x Beta-Lactam Cell Wall | 7.5 | MODIFY | PARTIALLY_EXPLORED |
| T6: EIS x Gut Microbiome | 7.0 | MODIFY | PARTIALLY_EXPLORED |

## Domain Experts for Evaluation
- **E1 (LOX Percolation)**: Tumor biophysicist (ECM mechanics + imaging), percolation theorist (statistical mechanics), LOX biochemist
- **E2 (BAPN Titration)**: LOX pharmacologist, immuno-oncology clinician, mathematical physicist
- **E6 (VACF Diagnostic)**: Single-cell tracking biophysicist, anomalous diffusion theorist
- **E3 (Universality Measurement)**: Soft matter physicist (active particles), microfluidics engineer
- **E5 (Dynamic Percolation)**: ECM biologist, time-lapse imaging specialist
- **E4 (GAS Classifier)**: Spatial pathologist, chemokine biologist

## Cross-Model Validation
Post-QG agents dispatched in parallel:
- Cross-Model Validator (GPT-5.4 Pro + Gemini 3.1 Pro)
- Convergence Scanner (ClinicalTrials.gov, NIH Reporter, patents)
- Dataset Evidence Miner (UniProt, ChEMBL, STRING, HPA)
- Session Analyst (meta-learning update)

*Session completed: 2026-03-28 | Session ID: session-20260328-123317*
